Alphabet-spinoff Isomorphic Labs raises $2.1 billion in quest to ‘solve all disease’ with AI-based drug discovery tools

Isomorphic Labs, the Alphabet-backed AI drug design company led by Sir Demis Hassabis, who shared the 2024 Nobel Prize in Chemistry with John Jumper for their work on the protein structure prediction platform AlphaFold, announced a $2.1 billion Series B on May 12. The total outside capital raised to date is about$2.6 billion. Thrive… The post Alphabet-spinoff Isomorphic Labs raises $2.1 billion in quest to ‘solve all disease’ with AI-based drug discovery tools appeared first on Research & Devel